Alaunos Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Alaunos Therapeutics, Inc. (TCRT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$150.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-10
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$150.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$276.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$76.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$27.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$737.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$551.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$412.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$193.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 127 month |
|---|---|---|---|---|---|
| 2018-03-31 | -$150.00K 10-Q · filed 2018-05-10 | -$426.00K derived: sum of 2 quarters · filed 2018-05-10 | -$502.00K derived: sum of 3 quarters · filed 2018-05-10 | -$529.00K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$352.00K derived: sum of 2 quarters · filed 2018-03-01 | -$379.00K derived: sum of 3 quarters · filed 2018-03-01 | -$737.00K 10-K · filed 2018-03-01 | |
| 2017-09-30 | -$76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$103.00K derived: sum of 2 quarters · filed 2017-11-06 | -$461.00K 10-Q · filed 2017-11-06 | -$543.00K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$385.00K 10-Q · filed 2017-07-31 | -$467.00K derived: sum of 3 quarters · filed 2018-05-10 | -$679.00K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-03-31 | -$358.00K 10-Q · filed 2018-05-10 | -$440.00K derived: sum of 2 quarters · filed 2018-05-10 | -$652.00K derived: sum of 3 quarters · filed 2018-05-10 | -$752.00K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$294.00K derived: sum of 2 quarters · filed 2018-03-01 | -$394.00K derived: sum of 3 quarters · filed 2018-03-01 | -$551.00K 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$312.00K derived: sum of 2 quarters · filed 2017-11-06 | -$469.00K 10-Q · filed 2017-11-06 | -$856.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$257.00K 10-Q · filed 2017-07-31 | -$644.00K derived: sum of 3 quarters · filed 2018-03-01 | -$647.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | -$157.00K 10-Q · filed 2017-05-01 | -$544.00K derived: sum of 2 quarters · filed 2018-03-01 | -$547.00K derived: sum of 3 quarters · filed 2018-03-01 | -$552.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | -$387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$390.00K derived: sum of 2 quarters · filed 2018-03-01 | -$395.00K derived: sum of 3 quarters · filed 2018-03-01 | -$412.00K 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$8.00K derived: sum of 2 quarters · filed 2016-11-09 | -$25.00K 10-Q · filed 2016-11-09 | -$25.00K derived: sum of 4 quarters · filed 2017-02-16 | |
| 2015-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$22.00K 10-Q · filed 2016-08-09 | -$22.00K derived: sum of 3 quarters · filed 2017-02-16 | -$116.00K derived: sum of 4 quarters · filed 2017-02-16 | |
| 2015-03-31 | -$17.00K 10-Q · filed 2016-05-10 | -$17.00K derived: sum of 2 quarters · filed 2017-02-16 | -$111.00K derived: sum of 3 quarters · filed 2017-02-16 | -$208.00K derived: sum of 4 quarters · filed 2017-02-16 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$94.00K derived: sum of 2 quarters · filed 2017-02-16 | -$191.00K derived: sum of 3 quarters · filed 2017-02-16 | -$193.00K 10-K · filed 2017-02-16 | |
| 2014-09-30 | -$94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$191.00K derived: sum of 2 quarters · filed 2015-11-02 | -$193.00K 10-Q · filed 2015-11-02 | -$206.00K derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$99.00K 10-Q · filed 2015-08-10 | -$112.00K derived: sum of 3 quarters · filed 2016-02-24 | -$115.00K derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-03-31 | -$2.00K 10-Q · filed 2015-05-07 | -$15.00K derived: sum of 2 quarters · filed 2016-02-24 | -$18.00K derived: sum of 3 quarters · filed 2016-02-24 | -$19.00K derived: sum of 4 quarters · filed 2016-02-24 | -$4.76M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$16.00K derived: sum of 2 quarters · filed 2016-02-24 | -$17.00K derived: sum of 3 quarters · filed 2016-02-24 | -$131.00K 10-K · filed 2016-02-24 | |
| 2013-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$4.00K derived: sum of 2 quarters · filed 2014-10-30 | -$118.00K 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$115.00K 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$114.00K 10-Q · filed 2014-05-08 | ||||
| 2012-12-31 | -$1.56M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |